Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: November 2008
-
By Christopher P. Singer — In an October 31, 2008 press release, the U.S. Patent and Trademark Office announced the development of a work sharing plan between five major intellectual property offices. The representatives of the five offices, including Dr. Jung-Sik Koh, Commissioner of the Korean Intellectual Property Office (KIPO); Alison Brimelow, President of…
-
By Donald Zuhn — Yesterday, as President-elect Barack Obama addressed hundreds of thousands of Chicagoans in Grant Park and millions of viewers around the world, we took a look back at a number of prior Patent Docs reports that discussed some aspects of the President-elect's technology platform, including his positions on patent issues and…
-
By Donald Zuhn — Like many Americans, we spent Tuesday evening watching the presidential election returns come in, and now that Senator Barack Obama has been elected the 44th president of the United States, we thought it would be a good idea to take a look back at some of our previous reports discussing…
-
By Kevin E. Noonan — In the excitement of the Federal Circuit's en banc decision in In re Bielski, handed down last Thursday, it could be understandable that another opinion from the Federal Circuit reviewing a Patent Office determination of unpatentability, In re Alonso, might go unnoticed. Unfortunately, this decision continues the Federal Circuit's…
-
By Sherri Oslick — Applicants filing a PCT application with the U.S. Patent and Trademark Office as the Receiving Office now have another option for their selection of an International Search Authority (ISA) — IP Australia, the Australian Patent Office. Previously, Applicants were limited to the USPTO, the European Patent Office (EPO), or the…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. AstraZeneca Pharmaceuticals LP et al. v. Handa Pharmaceuticals, LLC et al.3:08-cv-05328; filed October 28, 2008 in the District Court of New Jersey…
-
November 10-11, 2008 – Patent Litigation 2008 (Practising Law Institute) – Atlanta, GA November 11-13, 2008 – 4th Biosimilars conference (Visiongain) – Philadelphia, PA November 12-14, 2008 – Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements (American Conference Institute) – New York, NY November 17-18, 2008 – Pharmaceutical and Biotech Patent Opinion Writing*** (American Conference Institute)…
Patent Docs 